Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113467033 | 11346703 | 3 | F | 201007 | 20160720 | 20150803 | 20160728 | PER | US-ELI_LILLY_AND_COMPANY-US200904007300 | ELI LILLY AND CO | 64.08 | YR | F | Y | 0.00000 | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113467033 | 11346703 | 1 | PS | ZYPREXA | OLANZAPINE | 1 | Unknown | 5 MG, QD | N | U | 20592 | 5 | MG | TABLET | QD | ||||
| 113467033 | 11346703 | 2 | SS | ZYPREXA | OLANZAPINE | 1 | Unknown | 10 MG, QD | N | U | 20592 | 10 | MG | TABLET | QD | ||||
| 113467033 | 11346703 | 3 | SS | ZYPREXA ZYDIS | OLANZAPINE | 1 | Unknown | 20 MG, QD | N | U | 0 | 20 | MG | DISPERSIBLE TABLET | QD | ||||
| 113467033 | 11346703 | 4 | SS | ZYPREXA ZYDIS | OLANZAPINE | 1 | Unknown | 15 MG, QD | N | U | 0 | 15 | MG | DISPERSIBLE TABLET | QD | ||||
| 113467033 | 11346703 | 5 | SS | ZYPREXA ZYDIS | OLANZAPINE | 1 | Unknown | UNK UNK, QD | N | U | 0 | DISPERSIBLE TABLET | QD | ||||||
| 113467033 | 11346703 | 6 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 60 MG, QD | 0 | 60 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113467033 | 11346703 | 1 | Bipolar disorder |
| 113467033 | 11346703 | 3 | Bipolar disorder |
| 113467033 | 11346703 | 6 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113467033 | 11346703 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113467033 | 11346703 | Anxiety | |
| 113467033 | 11346703 | Drug ineffective | |
| 113467033 | 11346703 | Fatigue | |
| 113467033 | 11346703 | Flat affect | |
| 113467033 | 11346703 | Food craving | |
| 113467033 | 11346703 | Gait deviation | |
| 113467033 | 11346703 | Heart rate increased | |
| 113467033 | 11346703 | Hypertension | |
| 113467033 | 11346703 | Lethargy | |
| 113467033 | 11346703 | Malaise | |
| 113467033 | 11346703 | Metabolic disorder | |
| 113467033 | 11346703 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113467033 | 11346703 | 3 | 2006 | 0 |